United States · FDA National Drug Code directory
ITVISMA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71894-200_68c25df1-ad2d-4bb0-8e19-e9a58b868d13
- Product NDC
- 71894-200
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- onasemnogene abeparvovec-brve
- Labeler
- Novartis Innovative Technologies Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20251124
- Source listing expiry
- 20271231
Source-listed ingredients
- ONASEMNOGENE ABEPARVOVEC — 40000000000000 [arb'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01) · 71894-200-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →